AAPG Competitors & Alternatives
Compare Ascentage Pharma Group International with similar stocks in the same industry
Biotechnology
AAPG
Main Stock$18.56
Tradestie Score
50
Market Cap
$3.68B
Revenue Growth
1.2%
Analyst Upside
+157.9%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.36
|
$1.97B | - | 48 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.38
|
$1.92B | - | 49 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$132.18
|
$1.92B | - | 57 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$56.97
|
$1.90B | 334.9 | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$34.35
|
$1.84B | - | 55 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.37
|
$1.81B | - | 55 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$4.16
|
$1.78B | - | 51 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$16.54
|
$1.78B | - | 47 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.10
|
$1.74B | - | 58 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$30.22
|
$1.68B | - | 55 | Compare |
More AAPG Analysis
Data updated: May 19, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry